Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. ACIU

Market Cap: $280.9M

AS

AC Immune S.A.

ACIU
NASDAQ (NASDAQ Global Market)USD
Purchase ACIU
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Executive

Andrea Pfeifer

Co-Founder, Chief Executive Officer & Director

Compensation
CHF 1,517,292
Martin Zugel

Interim CEO & Chairman of the Board

Compensation
Compensation not disclosed
Christopher Roberts

Chief Financial Officer & Vice President of Finance

Compensation
Compensation not disclosed
Piergiorgio Donati

Chief Operating Officer

Compensation
Compensation not disclosed
Matthias Maurer

Senior Vice President & General Counsel

Compensation
Compensation not disclosed
Günther Staffler

Executive Vice President of Development

Compensation
Compensation not disclosed
Mark Danton

Executive Vice President of Information Systems & Artificial Intelligence

Compensation
Compensation not disclosed
Bojana Portmann

SVP of Intellectual Property,Intellectual Property & Business Development

Compensation
Compensation not disclosed
Francesca Capotosti

Senior Vice President of Research

Compensation
Compensation not disclosed
Gary Anthony Waanders

Senior Vice President of Investor Relations & Corporate Communications

Compensation
Compensation not disclosed
Julien Rongere

Senior Vice President of Regulatory Affairs & Quality Assurance

Compensation
Compensation not disclosed
Oliver Sol

Vice President & Head of Clinical Development

Compensation
Compensation not disclosed